Gaining Multi-dimensional Insights into Cancer Heterogeneity: Co-analysis of CTCs and ctDNA from Liquid Biopsy Samples

Watch a 49-minute webinar exploring innovative approaches to analyzing cancer heterogeneity through the co-analysis of circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) from liquid biopsy samples. Led by Bio-Rad scientists Dr. Yoon-Tae Kang and Dr. Abiodun Bodunrin, learn about a streamlined workflow combining the Genesis Cell Isolation System with Droplet Digital PCR technology for comprehensive cancer analysis. Discover how this dual-isolation technique from a single liquid biopsy sample enables multi-dimensional molecular insights, using non-small cell lung cancer (NSCLC) as a case study for EGFR mutation detection. Understand the complementary nature of CTC and ctDNA analyses and how their combined examination provides unique perspectives on cancer heterogeneity at both cellular and genetic levels. The presentation includes optimized methods for blood component separation, cell-free DNA enrichment, and downstream molecular assays that advance our understanding of cancer progression, survival outcomes, and treatment effectiveness.